newsfilter
← Latest News
Business Wire·

Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM), a leading rare disease company, today announced that it will participate in the following upcoming investor conferences: H.C. Wainwright 4th Annual BioConnect Investor